90Y-ibritumomab tiuxetan (Zevalin) radioimmunotherapy for transformed B-cell non-Hodgkin’s lymphoma (NHL) patients - Bartlett, NL; Witzig, T; Gordon, L (Proc Am Soc Clin Oncol, 2002)